1 Min Read
March 13 (Reuters) - Medtronic Plc
* Medtronic receives FDA clearance for reveal linq(tm) insertable cardiac monitor (icm) with trurhythm(tm) detection Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.